"The US Food and Drug Administration (FDA) has approved Akorn Inc's phenylephrine hydrochloride ophthalmic solution (2.5% and 10%), the company has announced.
The alpha-1 adrenergic receptor agonist is commonly used by optometrists, ophtha"...
Zylet Patient Information including If I Miss a Dose
In this Article
- What is loteprednol and tobramycin ophthalmic (Zylet)?
- What are the possible side effects of loteprednol and tobramycin ophthalmic (Zylet)?
- What is the most important information I should know about loteprednol and tobramycin ophthalmic (Zylet)?
- What should I discuss with my healthcare provider before using loteprednol and tobramycin ophthalmic (Zylet)?
- How should I use loteprednol and tobramycin ophthalmic (Zylet)?
- What happens if I miss a dose (Zylet)?
- What happens if I overdose (Zylet)?
- What should I avoid while using loteprednol and tobramycin ophthalmic (Zylet)?
- What other drugs will affect loteprednol and tobramycin ophthalmic (Zylet)?
- Where can I get more information?
What happens if I miss a dose (Zylet)?
Apply the missed dose as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and apply the next regularly scheduled dose as directed. Do not use a double dose of this medication.
What happens if I overdose (Zylet)?
An overdose of loteprednol and tobramycin ophthalmic is unlikely to threaten life.
If an overdose is suspected, or if the drops have been ingested, contact an emergency room or poison control center for advice.
What should I avoid while using loteprednol and tobramycin ophthalmic (Zylet)?
Do not touch the dropper or tube opening to any surface, including your eyes or hands. The dropper or tube opening is sterile. If it becomes contaminated, it could cause an infection in the eye.
Use caution when driving, operating machinery, or performing other hazardous activities. Tobramycin ophthalmic may cause blurred vision. If you experience blurred vision, avoid these activities.
If you wear contact lenses, ask your doctor if you should wear them during treatment with tobramycin ophthalmic. After applying the medication, wait at least 15 minutes before inserting contact lenses, unless otherwise directed by your doctor.
Do not use other eye drops or medications during treatment with tobramycin ophthalmic unless otherwise directed by your doctor.
Do not touch the dropper to any surface, including the eyes or hands. The dropper is sterile. If it becomes contaminated, it could cause an infection in the eye.
If you wear contact lenses, remove them before applying loteprednol and tobramycin ophthalmic. Ask your doctor if contact lenses can be reinserted after application of the medication. Loteprednol and tobramycin ophthalmic may contain a preservative (benzalkonium chloride), which may cause discoloration of contact lenses.
What other drugs will affect loteprednol and tobramycin ophthalmic (Zylet)?
Do not use other eye drops or eye medications during treatment with loteprednol and tobramycin ophthalmic without first talking to your doctor.
Drugs other than those listed here may also interact with loteprednol and tobramycin ophthalmic. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines, including vitamins, minerals, and herbal products.
Where can I get more information?
Your pharmacist has additional information about loteprednol and tobramycin ophthalmic written for health professionals that you may read.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 1996-2013 Cerner Multum, Inc. Version: 2.03. Revision date: 12/15/2010.
Your use of the content provided in this service indicates that you have read,understood and agree to the End-User License Agreement,which can be accessed by clicking on this link.
Additional Zylet Information
Zylet - User Reviews
Zylet User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.